About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RAAS Inhibitor Drugs in Dialysis Patients | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 4NCT01635387

RAAS Inhibitor Drugs in Dialysis Patients

Hypertensive haemodialysis patients are at high risk for cardiovascular events. This study was undertaken to ascertain whether the upstream of aliskirne, a direct renin inhibitor improves mortality an...

Lead sponsor: University of Campania Luigi Vanvitelli•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Campania Luigi Vanvitelli

Collaborators

IRCCS San Raffaele

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•chronic kidney disease stage 5
•undergoing maintenance haemodialysis for a minimum of 3 months
•existing arterial hypertension or
•history of arterial hypertension or
•resting blood pressure ≥140/90 mmHg or
•antihypertensive medication
•man and female
•18 years and older.

Exclusion Criteria

•recent myocardial infarction (less than 3 months)
•atrial fibrillation/atrial flutter
•hypotension with systolic blood pressure of \<90 mmHg
•high-grade aortic stenosis
•left ventricular ejection fration \<50%
•known allergy to aliskiren
•severe disorders of liver function

Related studies

RECRUITINGPhase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT07218029 · Pulmonary Arterial Hypertension

Natural History of Noncirrhotic Portal Hypertension

NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more

RECRUITINGPhase 3

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

NCT07365332 · Pulmonary Arterial Hypertension

RECRUITINGPhase 1/2

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

NCT06647511 · Gestational Hypertension

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 9, 2012Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE4

Enrollment350

Start dateFeb 2010

Last updatedJul 9, 2012

Condition

Hypertension End Stage Renal Disease

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 9, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions